{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:47Z","timestamp":1792782707891,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"East Metropolitan Health Service","id":[{"id":"https:\/\/ror.org\/02baa5g50","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Orthop Surg Traumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This article explores the mechanism of action of atypical femoral fractures (AFF), specifically focussing on osteoporosis, management challenges, and the implications for clinical practice. Non-union of AFF can result in severe pain, deformity and restricted mobility\u2014all of which will have a detrimental impact on the patients\u2019 quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This review consolidates the current literature regarding non-union after bisphosphonate-associated atypical femoral fractures, providing a revision tool for higher examinations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method\/findings<\/jats:title>\n                    <jats:p>An extensive search strategy was conducted for relevant studies up to April 2025 using several online databases including Cochrane Library, Embase, National Library of Medicine and PubMed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although this topic is prominent among surgical colleagues and in higher level examinations, we identified that persistent gaps in knowledge exist in this area. Our review compiles the available knowledge as a revision tool for our colleagues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00590-026-04677-2","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:15:51Z","timestamp":1771416951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-union after bisphosphonate-associated atypical femoral fractures: a review of the current literature"],"prefix":"10.1007","volume":"36","author":[{"given":"Jack","family":"Dowling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"O\u2019Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"4677_CR1","first-page":"176","volume-title":"Bisphosphonates in bone disease. From the laboratory to the patient","author":"H Fleisch","year":"1995","unstructured":"Fleisch H (1995) Bisphosphonates in bone disease. From the laboratory to the patient. The Parthenon Publishing Group, New York\/London, p 176"},{"key":"4677_CR2","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.injury.2017.04.020","volume":"48","author":"BP Cunningham","year":"2017","unstructured":"Cunningham BP et al (2017) Fracture healing: a review of clinical, imaging and laboratory diagnostic options. Injury 48:S69\u2013S75. https:\/\/doi.org\/10.1016\/j.injury.2017.04.020","journal-title":"Injury"},{"issue":"10","key":"4677_CR3","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/nejmc1403799","volume":"371","author":"J Schilcher","year":"2014","unstructured":"Schilcher J et al (2014) Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med 371(10):974\u2013976. https:\/\/doi.org\/10.1056\/nejmc1403799","journal-title":"N Engl J Med"},{"issue":"2","key":"4677_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bone.2013.09.008","volume":"57","author":"DK Wysowski","year":"2013","unstructured":"Wysowski DK, Greene P (2013) Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002\u20132012. Bone 57(2):423\u2013428. https:\/\/doi.org\/10.1016\/j.bone.2013.09.008","journal-title":"Bone"},{"issue":"4","key":"4677_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/bf02547227","volume":"11","author":"A Jung","year":"1973","unstructured":"Jung A, Bisaz S, Fleisch H (1973) The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res 11(4):269\u2013280. https:\/\/doi.org\/10.1007\/bf02547227","journal-title":"Calcif Tissue Res"},{"issue":"12","key":"4677_CR6","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1172\/jci118722","volume":"97","author":"GA Rodan","year":"1996","unstructured":"Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Investig 97(12):2692\u20132696. https:\/\/doi.org\/10.1172\/jci118722","journal-title":"J Clin Investig"},{"issue":"7","key":"4677_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ejca.2010.02.041","volume":"46","author":"HL Neville-Webbe","year":"2010","unstructured":"Neville-Webbe HL, Coleman RE (2010) Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease. Eur J Cancer 46(7):1211\u20131222. https:\/\/doi.org\/10.1016\/j.ejca.2010.02.041","journal-title":"Eur J Cancer"},{"issue":"1","key":"4677_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RGG Russell","year":"2007","unstructured":"Russell RGG et al (2007) Bisphosphonates. Ann N Y Acad Sci 1117(1):209\u2013257. https:\/\/doi.org\/10.1196\/annals.1402.089","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"4677_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T et al (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15(4):613\u2013620. https:\/\/doi.org\/10.1359\/jbmr.2000.15.4.613","journal-title":"J Bone Miner Res"},{"issue":"6","key":"4677_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1359\/jbmr.1999.14.6.969","volume":"14","author":"J Li","year":"1999","unstructured":"Li J et al (1999) Effect of bisphosphonate (Incadronate) on fracture healing of long bones in rats. J Bone Miner Res 14(6):969\u2013979. https:\/\/doi.org\/10.1359\/jbmr.1999.14.6.969","journal-title":"J Bone Miner Res"},{"key":"4677_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2015.79","author":"AL Boskey","year":"2015","unstructured":"Boskey AL (2015) Bone composition: relationship to bone fragility and anti-osteoporotic drug effects. BoneKEy Rep. https:\/\/doi.org\/10.1038\/bonekey.2015.79","journal-title":"BoneKEy Rep"},{"key":"4677_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bone.2014.06.008","volume":"66","author":"Y Saita","year":"2014","unstructured":"Saita Y et al (2014) The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment. Bone 66:105\u2013110. https:\/\/doi.org\/10.1016\/j.bone.2014.06.008","journal-title":"Bone"},{"issue":"11","key":"4677_CR13","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.injury.2014.08.037","volume":"45","author":"Y Oh","year":"2014","unstructured":"Oh Y et al (2014) Potential pathogenic mechanism for stress fractures of the bowed femoral shaft in the elderly: mechanical analysis by the CT-based finite element method. Injury 45(11):1764\u20131771. https:\/\/doi.org\/10.1016\/j.injury.2014.08.037","journal-title":"Injury"},{"issue":"4","key":"4677_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/2040622315584114","volume":"6","author":"Y Saita","year":"2015","unstructured":"Saita Y, Ishijima M, Kaneko K (2015) Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications. Ther Adv Chronic Dis 6(4):185\u2013193. https:\/\/doi.org\/10.1177\/2040622315584114","journal-title":"Ther Adv Chronic Dis"},{"issue":"3","key":"4677_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1302\/0301-620x.89b3.18146","volume":"89-B","author":"S-k Goh","year":"2007","unstructured":"Goh S-k et al (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy. J. Bone Jt. Surg. British 89-B(3):349\u2013353. https:\/\/doi.org\/10.1302\/0301-620x.89b3.18146","journal-title":"J. Bone Jt. Surg. British"},{"issue":"11","key":"4677_CR16","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the american society for bone and mineral research. J Bone Miner Res 25(11):2267\u20132294. https:\/\/doi.org\/10.1002\/jbmr.253","journal-title":"J Bone Miner Res"},{"issue":"8","key":"4677_CR17","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jbmr.1893","volume":"28","author":"L Gedmintas","year":"2013","unstructured":"Gedmintas L, Solomon DH, Kim SC (2013) Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res 28(8):1729\u20131737. https:\/\/doi.org\/10.1002\/jbmr.1893","journal-title":"J Bone Miner Res"},{"issue":"8","key":"4677_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/nejmoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"Black DM et al (2020) Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med 383(8):743\u2013753. https:\/\/doi.org\/10.1056\/nejmoa1916525","journal-title":"N Engl J Med"},{"issue":"4","key":"4677_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00198-014-3007-8","volume":"26","author":"H Molvik","year":"2015","unstructured":"Molvik H, Khan W (2015) Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int 26(4):1251\u20131260. https:\/\/doi.org\/10.1007\/s00198-014-3007-8","journal-title":"Osteoporos Int"},{"issue":"19","key":"4677_CR20","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1056\/nejmc0910389","volume":"362","author":"CM Girgis","year":"2010","unstructured":"Girgis CM, Sher D, Seibel MJ (2010) Atypical femoral fractures and bisphosphonate use. N Engl J Med 362(19):1848\u20131849. https:\/\/doi.org\/10.1056\/nejmc0910389","journal-title":"N Engl J Med"},{"issue":"3","key":"4677_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ans.12018","volume":"83","author":"J Shkolnikova","year":"2012","unstructured":"Shkolnikova J, Flynn J, Choong P (2012) Burden of bisphosphonate-associated femoral fractures. ANZ J Surg 83(3):175\u2013181. https:\/\/doi.org\/10.1111\/ans.12018","journal-title":"ANZ J Surg"},{"issue":"8","key":"4677_CR22","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","volume":"20","author":"BA Lenart","year":"2008","unstructured":"Lenart BA et al (2008) Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 20(8):1353\u20131362. https:\/\/doi.org\/10.1007\/s00198-008-0805-x","journal-title":"Osteoporos Int"},{"issue":"11","key":"4677_CR23","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.injury.2013.08.003","volume":"44","author":"C Copuroglu","year":"2013","unstructured":"Copuroglu C, Calori GM, Giannoudis PV (2013) Fracture non-union: who is at risk? Injury 44(11):1379\u20131382. https:\/\/doi.org\/10.1016\/j.injury.2013.08.003","journal-title":"Injury"},{"issue":"4","key":"4677_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/ans.12536","volume":"84","author":"AJ Ng","year":"2014","unstructured":"Ng AJ et al (2014) Delayed\/non\u2010union of upper limb fractures with bisphosphonates: systematic review and recommendations. ANZ J Surg 84(4):218\u2013224. https:\/\/doi.org\/10.1111\/ans.12536","journal-title":"ANZ J Surg"},{"issue":"5","key":"4677_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00774-014-0611-9","volume":"33","author":"M Kharazmi","year":"2014","unstructured":"Kharazmi M, Micha\u00eblsson K, Hallberg P (2014) Prodromal symptoms in patients with bisphosphonate-associated atypical fractures of the femur. J Bone Miner Metab 33(5):516\u2013522. https:\/\/doi.org\/10.1007\/s00774-014-0611-9","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"4677_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","volume":"39","author":"EBK Kwek","year":"2008","unstructured":"Kwek EBK et al (2008) An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39(2):224\u2013231. https:\/\/doi.org\/10.1016\/j.injury.2007.08.036","journal-title":"Injury"},{"issue":"1","key":"4677_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/230949901101900121","volume":"19","author":"K Wang","year":"2011","unstructured":"Wang K et al (2011) Alendronate-associated femoral insufficiency fractures and femoral stress reactions. J Orthop Surg 19(1):89\u201392. https:\/\/doi.org\/10.1177\/230949901101900121","journal-title":"J Orthop Surg"},{"issue":"12","key":"4677_CR28","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.7205\/milmed-d-14-00736","volume":"180","author":"J Ernat","year":"2015","unstructured":"Ernat J et al (2015) Radiographic changes and fracture in patients having received bisphosphonate therapy for \u22655 years at a single institution. Mil Med 180(12):1214\u20131218. https:\/\/doi.org\/10.7205\/milmed-d-14-00736","journal-title":"Mil Med"},{"issue":"5","key":"4677_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/bot.0b013e318172841c","volume":"22","author":"AS Neviaser","year":"2008","unstructured":"Neviaser AS et al (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22(5):346\u2013350. https:\/\/doi.org\/10.1097\/bot.0b013e318172841c","journal-title":"J Orthop Trauma"},{"issue":"6","key":"4677_CR30","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00198-008-0759-z","volume":"20","author":"DH Solomon","year":"2008","unstructured":"Solomon DH et al (2008) The relation between bisphosphonate use and non-union of fractures of the humerus in older adults. Osteoporos Int 20(6):895\u2013901. https:\/\/doi.org\/10.1007\/s00198-008-0759-z","journal-title":"Osteoporos Int"},{"key":"4677_CR31","doi-asserted-by":"publisher","unstructured":"\u015eahin K (2019) Atypical femoral fractures related to bisphosphonate use: a comprehensive review of 19 patients. Turk J Trauma Emergency Surg [Preprint]. https:\/\/doi.org\/10.14744\/tjtes.2019.46595","DOI":"10.14744\/tjtes.2019.46595"},{"issue":"5","key":"4677_CR32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1302\/0301-620x.96b5.32887","volume":"96-B","author":"BJX Teo","year":"2014","unstructured":"Teo BJX et al (2014) Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy. Bone Joint J 96-B(5):658\u2013664. https:\/\/doi.org\/10.1302\/0301-620x.96b5.32887","journal-title":"Bone Joint J"},{"issue":"2","key":"4677_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jor.2017.01.002","volume":"14","author":"C Kayali","year":"2017","unstructured":"Kayali C et al (2017) Atypical femoral shaft fractures secondary to long-term bisphosphonate therapy. J Orthop 14(2):226\u2013230. https:\/\/doi.org\/10.1016\/j.jor.2017.01.002","journal-title":"J Orthop"},{"issue":"5","key":"4677_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1308\/003588415x14181254789321","volume":"97","author":"B Yue","year":"2015","unstructured":"Yue B et al (2015) Delayed healing of lower limb fractures with bisphosphonate therapy. Ann R Coll Surg Engl 97(5):333\u2013338. https:\/\/doi.org\/10.1308\/003588415x14181254789321","journal-title":"Ann R Coll Surg Engl"},{"issue":"3","key":"4677_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1302\/0301-620x.99b3.bjj-2016-0276.r2","volume":"99-B","author":"A Koh","year":"2017","unstructured":"Koh A, Guerado E, Giannoudis PV (2017) Atypical femoral fractures related to bisphosphonate treatment. Bone Jt J 99-B(3):295\u2013302. https:\/\/doi.org\/10.1302\/0301-620x.99b3.bjj-2016-0276.r2","journal-title":"Bone Jt J"},{"issue":"3","key":"4677_CR36","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.injury.2020.09.051","volume":"52","author":"MT Nagy","year":"2020","unstructured":"Nagy MT et al (2020) Outcome of revision surgery for bisphosphonate related subtrochanteric fracture non-union following failed intramedullary nailing. Injury 52(3):582\u2013588. https:\/\/doi.org\/10.1016\/j.injury.2020.09.051","journal-title":"Injury"},{"issue":"3","key":"4677_CR37","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV et al (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294\u20131301. https:\/\/doi.org\/10.1210\/jc.2004-0952","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"4677_CR38","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2165\/0003495-200868180-00012","volume":"68","author":"SKA Blick","year":"2008","unstructured":"Blick SKA, Dhillon S, Keam SJ (2008) Teriparatide. Drugs 68(18):2709\u20132737. https:\/\/doi.org\/10.2165\/0003495-200868180-00012","journal-title":"Drugs"},{"key":"4677_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.22203\/ecm.v035a25","volume":"35","author":"V Fischer","year":"2018","unstructured":"Fischer V et al (2018) Calcium and vitamin D in bone fracture healing and post-traumatic bone turnover. Eur Cells Mater 35:365\u2013385. https:\/\/doi.org\/10.22203\/ecm.v035a25","journal-title":"Eur Cells Mater"},{"issue":"4","key":"4677_CR40","doi-asserted-by":"publisher","DOI":"10.11005\/jbm.2015.22.4.183","volume":"22","author":"G-I Im","year":"2015","unstructured":"Im G-I, Lee S-H (2015) Effect of teriparatide on healing of atypical femoral fractures: a systemic review. J Bone Metab 22(4):183. https:\/\/doi.org\/10.11005\/jbm.2015.22.4.183","journal-title":"J Bone Metab"},{"issue":"2","key":"4677_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11420-012-9275-y","volume":"8","author":"A Saleh","year":"2012","unstructured":"Saleh A et al (2012) Management strategy for symptomatic bisphosphonate-associated incomplete atypical femoral fractures. HSS J.\u00ae Musculoskelet J Hosp Special Surg 8(2):103\u2013110. https:\/\/doi.org\/10.1007\/s11420-012-9275-y","journal-title":"HSS J.\u00ae Musculoskelet J Hosp Special Surg"},{"issue":"2","key":"4677_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jbmr.3051","volume":"32","author":"F Cosman","year":"2016","unstructured":"Cosman F, Nieves JW, Dempster DW (2016) Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis. J Bone Miner Res 32(2):198\u2013202. https:\/\/doi.org\/10.1002\/jbmr.3051","journal-title":"J Bone Miner Res"},{"issue":"5","key":"4677_CR43","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1359\/jbmr.040117","volume":"19","author":"B Ettinger","year":"2004","unstructured":"Ettinger B et al (2004) Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Miner Res 19(5):745\u2013751. https:\/\/doi.org\/10.1359\/jbmr.040117","journal-title":"J Bone Miner Res"},{"key":"4677_CR44","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20120525-51","author":"MK Grady","year":"2012","unstructured":"Grady MK, Watson JT, Cannada LK (2012) Treatment of femoral fracture nonunion after long-term bisphosphonate use. Orthopedics. https:\/\/doi.org\/10.3928\/01477447-20120525-51","journal-title":"Orthopedics"},{"issue":"1","key":"4677_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ocl.2012.08.005","volume":"44","author":"RJ Steffner","year":"2012","unstructured":"Steffner RJ, Lee MA (2012) Emerging concepts in upper extremity trauma. Orthop Clin North Am 44(1):21\u201333. https:\/\/doi.org\/10.1016\/j.ocl.2012.08.005","journal-title":"Orthop Clin North Am"},{"issue":"4","key":"4677_CR46","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cpm.2007.06.005","volume":"24","author":"SM Rush","year":"2007","unstructured":"Rush SM (2007) Reconstructive options for failed flatfoot surgery. Clin Podiatr Med Surg 24(4):779\u2013788. https:\/\/doi.org\/10.1016\/j.cpm.2007.06.005","journal-title":"Clin Podiatr Med Surg"},{"issue":"3","key":"4677_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00005131-198909000-00002","volume":"3","author":"EM Younger","year":"1989","unstructured":"Younger EM, Chapman MW (1989) Morbidity at bone graft donor sites. J Orthop Trauma 3(3):192\u2013195. https:\/\/doi.org\/10.1097\/00005131-198909000-00002","journal-title":"J Orthop Trauma"},{"key":"4677_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00003086-199608000-00037","volume":"329","author":"ED Arrington","year":"1996","unstructured":"Arrington ED et al (1996) Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329:300\u2013309. https:\/\/doi.org\/10.1097\/00003086-199608000-00037","journal-title":"Clin Orthop Relat Res"},{"issue":"11","key":"4677_CR49","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.injury.2007.05.013","volume":"38","author":"S Shukla","year":"2007","unstructured":"Shukla S et al (2007) Outcome of traumatic subtrochanteric femoral fractures fixed using cephalo-medullary nails. Injury 38(11):1286\u20131293. https:\/\/doi.org\/10.1016\/j.injury.2007.05.013","journal-title":"Injury"},{"issue":"6","key":"4677_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.injury.2010.01.114","volume":"41","author":"J Park","year":"2010","unstructured":"Park J, Yang KH (2010) Correction of malalignment in proximal femoral nailing\u2014reduction technique of displaced proximal fragment. Injury 41(6):634\u2013638. https:\/\/doi.org\/10.1016\/j.injury.2010.01.114","journal-title":"Injury"},{"key":"4677_CR51","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/s0020-1383(13)70017-2","volume":"44","author":"PV Giannoudis","year":"2013","unstructured":"Giannoudis PV et al (2013) Subtrochanteric fracture non-unions with implant failure managed with the \u201cDiamond\u201d concept. Injury 44:S76\u2013S81. https:\/\/doi.org\/10.1016\/s0020-1383(13)70017-2","journal-title":"Injury"},{"key":"4677_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-019-2775-x","author":"V Freigang","year":"2019","unstructured":"Freigang V et al (2019) Risk factor analysis for delayed union after subtrochanteric femur fracture: quality of reduction and valgization are the key to success. BMC Musculoskelet Disord. https:\/\/doi.org\/10.1186\/s12891-019-2775-x","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"4677_CR53","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1007\/s11999-013-2963-1","volume":"472","author":"KA Egol","year":"2013","unstructured":"Egol KA et al (2013) Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails. Clin Orthop Relat Res 472(9):2728\u20132734. https:\/\/doi.org\/10.1007\/s11999-013-2963-1","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"4677_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0021-9290(85)90006-5","volume":"18","author":"EJ Cheal","year":"1985","unstructured":"Cheal EJ et al (1985) Stress analysis of compression plate fixation and its effects on long bone remodeling. J Biomech 18(2):141\u2013150. https:\/\/doi.org\/10.1016\/0021-9290(85)90006-5","journal-title":"J Biomech"},{"issue":"8","key":"4677_CR55","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/bot.0000000000001642","volume":"33","author":"RK Leighton","year":"2019","unstructured":"Leighton RK, De Dios Robinson J, Giannoudis PV (2019) Nonunions of bisphosphonate fractures of the femur: presentation, etiopathogenesis, diagnosis, and operative treatment. J Orthop Trauma 33(8):S14\u2013S20. https:\/\/doi.org\/10.1097\/bot.0000000000001642","journal-title":"J Orthop Trauma"},{"issue":"4","key":"4677_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.fas.2019.05.009","volume":"26","author":"H Majeed","year":"2019","unstructured":"Majeed H et al (2019) Clinical and patient-reported outcomes following Low Intensity Pulsed Ultrasound (LIPUS, Exogen) for established post-traumatic and post-surgical nonunion in the foot and ankle. Foot Ankle Surg 26(4):405\u2013411. https:\/\/doi.org\/10.1016\/j.fas.2019.05.009","journal-title":"Foot Ankle Surg"}],"container-title":["European Journal of Orthopaedic Surgery &amp; Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-026-04677-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-026-04677-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-026-04677-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:39:02Z","timestamp":1792096742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-026-04677-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4677"],"URL":"https:\/\/doi.org\/10.1007\/s00590-026-04677-2","relation":{},"ISSN":["1432-1068"],"issn-type":[{"value":"1432-1068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: due to funding information section was incorrect in the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"105"}}